DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Pfisterer J, Shannon CM, Baumann K. et al.
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.
Lancet Oncol 2020;
21: 699-709
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.